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Interferon Regulatory Factor 6 Is Necessary,
but Not Sufficient, for Keratinocyte Differentiation
Leah C. Biggs1,2, Lindsey Rhea2, Brian C. Schutte3,4 and Martine Dunnwald1,2
Regulation of epidermal proliferation and differentiation is critical for maintenance of cutaneous homeostasis.
Interferon Regulatory Factor 6 (Irf6)-deficient mice die perinatally and exhibit ectopic proliferation and
defective epidermal differentiation. We sought to determine whether these disruptions of epidermal function
were cell autonomous, and used embryonic Irf6/ keratinocytes to understand the specific role of Irf6 in
keratinocyte proliferation and differentiation. In the absence of Irf6, keratinocytes exhibited a heterogeneous
phenotype with the presence of large cells. Irf6/ keratinocytes displayed increased colony-forming efficiency
compared with wild-type cells, suggesting that Irf6 represses long-term proliferation. Irf6 was present at low
levels in wild-type keratinocytes in culture, and upregulated after induction of differentiation in vitro, along
with upregulation of markers of early differentiation. However, Irf6/ keratinocytes did not express markers of
terminal differentiation. Overexpression of Irf6 in wild-type keratinocytes was insufficient to induce expression
of markers of differentiation under growing conditions. Together, these results indicated that Irf6 is necessary,
but not sufficient, for keratinocyte differentiation. Finally, using a transgenic mouse expressing Lac-Z under the
regulation of an enhancer element 9.7 kb upstream of the Irf6 start site, we demonstrated that this element
contributes to the regulation of Irf6 in the epidermis and keratinocytes in culture.
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INTRODUCTION
Maintenance of the epidermis requires a delicate balance
between restricted proliferation of keratinocytes in the basal
layer and differentiation of basal keratinocytes into the
stratum corneum. The regulation of epidermal differentiation
is a complex process that requires spatial and temporal
regulation of many genes, including Keratin (Krt) 14 and Krt5,
which are expressed in the basal layer and shut down
suprabasally when other genes, such as involucrin, loricrin,
and filaggrin, are upregulated (Eckert, 1989). In addition,
transcription factors such as p63 (Mills et al., 1999; Yang
et al., 1999), AP1 (Welter et al., 1995) and AP2 (Leask et al.,
1991) family members, C/EBP (Maytin and Habener, 1998),
and SP1 (Byrne and Fuchs, 1993) are involved in regulating
epidermal differentiation. Recently, we identified Interferon
Regulatory Factor 6 (Irf6) as a new critical transcriptional
regulator of epidermal differentiation (Ingraham et al., 2006;
Richardson et al., 2006).
Mutations in IRF6 cause two allelic orofacial clefting
syndromes, Van der Woude and popliteal pterygium
syndromes (Kondo et al., 2002). Removal of Irf6 in mice
results in severe epidermal malfunction, in addition to limb
and craniofacial abnormalities (Ingraham et al., 2006), and is
a phenocopy of the Sfn (Fisher et al., 1987; Herron et al.,
2005), Ikka (Hu et al., 1999; Takeda et al., 1999), and Rip4
(Holland et al., 2002) knockout mice, genes necessary for
proper epidermal morphogenesis. Irf6-deficient mice lack a
functional barrier and are perinatal lethal.
More specifically, Irf6 is expressed suprabasally in
the embryonic (e) epidermis 17.5 days after conception
(Ingraham et al., 2006). Examination of the epidermis of
Irf6-deficient mice revealed a lack of keratohyalin granules
and stratum corneum that is accompanied by the absence of
loricrin and filaggrin. Concomitantly, proliferative keratino-
cytes were found in the spinous layer, along with ectopic p63
and Krt14 (Ingraham et al., 2006). These observations are
indicative of a role for Irf6 as a repressor of proliferation
and a promoter of differentiation. Recently, a feedback loop
between Irf6 and p63 was identified (Moretti et al., 2010;
Thomason et al., 2010). This occurs by DNp63 directly
binding a conserved region 9.7 kb upstream of the Irf6
transcriptional start site and inducing transcription of Irf6,
which in turn downregulates DNp63 posttranslationally
(Moretti et al., 2010). Interestingly, the p63-binding site is
located in a multispecies conserved sequence (MCS) genomic
region that has Irf6 enhancer activity (Rahimov et al., 2008).
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However, whether this enhancer region also regulates Irf6 in
adult keratinocytes is unknown.
In this study, we provide evidence that Irf6 is necessary,
but not sufficient, for keratinocyte terminal differentiation.
These data, along with the requirement of Irf6 for epidermal
development and maintenance in vivo, suggest that the effect
of Irf6 is specific to keratinocytes. Furthermore, we demon-
strate that an MCS enhancer, 9.7 kb upstream of the start site
of Irf6, contributes to its regulation in adult epidermis and
keratinocytes in culture.
RESULTS
Irf6-deficient keratinocytes display an abnormal but epithelial
phenotype
We successfully cultured keratinocytes from e17.5 wild-type
and Irf6/ embryos. Microscopic observations revealed
wild-type keratinocytes that appeared cobblestone-like, and
largely uniform in size. In contrast, Irf6/ keratinocytes
exhibited a heterogeneous population with small, normal,
cobblestone-like cells among cells that were much larger in
size and irregularly shaped (Figure 1a). The overall cellular
area of Irf6/ keratinocytes was significantly increased
compared with wild type (Figure 1b), as well as the
distribution of the cellular size, with an increase in the
proportion of larger cells in the mutant cells (Figure 1b).
However, cellular volume was unchanged between the two
populations of cells (Figure 1b). An increase in cellular size
has been observed with loss of the epithelial phenotype
during epithelial-to-mesenchymal transition (Lamouille and
Derynck, 2007). To determine whether the Irf6/ keratino-
cytes had initiated epithelial-to-mesenchymal transition, we
performed immunostaining to detect either the loss of basal
epidermal marker, Krt14, or the gain of the mesenchymal
marker vimentin (Steinert and Roop, 1988; Figure 1c, top
row). Both wild-type and mutant keratinocytes expressed
Krt14 and lacked vimentin, demonstrating their epithelial
phenotype. A few vimentin-positive cells were present in
both cultures. However, they were Krt14 negative and
dendritic-like. This is consistent with the only vimentin-
positive cells being melanocytes and Langerhans cells in the
epidermis (Franke et al., 1979). Together, these data show
that although there is a difference in cellular size distribution,
Irf6/ keratinocytes retain epithelial characteristics and do
not express vimentin.
Previous work demonstrated a regulatory relationship
between p63 and Irf6 (Moretti et al., 2010; Thomason et al.,
2010). To localize Irf6 in murine embryonic keratino-
cytes, we performed immunostaining for Irf6 and p63 on wild-
type and Irf6/ keratinocytes under basal growing conditions
(Figure 1c, bottom row). We observed Irf6 largely in the
cytoplasm of the cells, whereas no signal was detected in Irf6/
keratinocytes. p63 was localized in the nucleus of keratinocytes
and was present in both wild-type and Irf6/ keratinocytes.
Irf6 restricts the long-term proliferative potential of
keratinocytes
Keratinocytes shut down proliferation in order to commit to
terminal differentiation. To determine whether Irf6 represses
proliferation in vitro, we compared the percentage of BrdU
incorporation in wild-type andmutant keratinocytes (Figure 2,
top left panel). We complemented the assay by evaluating the
cell cycle profile of the same cells (Figure 2, top right panel).
We did not observe statistically significant differences
between the two groups. Data from our in vivo studies
indicated the presence of ectopic proliferative keratinocytes
in the absence of Irf6, whereas the proliferation of basal
keratinocytes was not altered (Ingraham et al., 2006).
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Figure 1. Characterization of Irf6/ keratinocytes. (a) Phase-contrast
photomicrographs of Irf6þ /þ (left) and Irf6/ keratinocytes (right). Black
arrows indicate larger keratinocytes in the Irf6/ population. (b) Cellular area
of wild-type and Irf6/ keratinocyte was traced on images as in a and
averages (N¼ 6 or 7) plotted. *Po0.05 after Student’s t-test. Distribution
among three arbitrary categories of cellular sizes was calculated, and the
difference determined by w2-contingency test (*Po0.05). Average of cellular
volume (N¼ 6 or 7) after trypsinization was plotted. (c) Immunofluorescent
staining of Krt14 (green, top row) and vimentin (red, top row), and Irf6 (red,
bottom row) and p63 (green, bottom row). Nuclear DNA is labeled with 4,6-
diamidino-2-phenylindole (blue). White arrows indicate vimentin-positive,
Krt14-negative melanocytes. Bar¼100 mm. Irf6, Interferon Regulatory Factor
6; Krt, Keratin.
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As these results may indicate a difference in long-term
proliferative capacity, we performed a proliferation assay in
which we counted the number of cells 6 and 10 days after
plating (Figure 2, bottom left panel). Consistent with our BrdU
incorporation assay and cell cycle analysis, we did not
observe a difference 6 days after plating. However, Irf6/
keratinocytes were more numerous than wild-type cells after
10 days. In addition, we found that in the absence of Irf6,
keratinocytes were more efficient at forming colonies than
wild-type cells (Figure 2, bottom right). Together, these data
suggest that Irf6 restricts the long-term proliferative capacity
of keratinocytes.
Irf6 is necessary for keratinocyte terminal differentiation
in vitro
Loss of Irf6 in the mouse resulted in abnormal epidermal
morphogenesis. This prompted us to directly test whether
Irf6 functions in a keratinocyte-autonomous manner to
regulate keratinocyte differentiation. Murine keratinocytes
can be induced to differentiate by increasing the calcium in
the culture medium (Yuspa et al., 1989; Hager et al., 1999).
After reaching confluence in NMedium (0.06mM CaCl2),
wild-type and Irf6/ keratinocytes were purged from growth
factors (LoCal medium, 0.06mM CaCl2) for 24 hours, then
switched for keratinocyte serum-free medium with 0.15mM
CaCl2 (K0.15) to induce differentiation. Both wild-type and
Irf6/ keratinocytes exhibited their characteristic cellular
morphology (Figure 3a and d), similar to that previously
observed in NMedium (Figure 1). After 72 hours in K0.15,
wild-type keratinocytes appeared stratified in the middle
of colonies, eventually forming peaks of elongated cells,
as evidenced by birefringent scattering of light (Figure 3b).
In contrast, the Irf6/ cells remained mainly as a monolayer
(Figure 3e).
Western blot analysis revealed low levels of Irf6 in wild-
type cells under growing conditions (NMedium), and its
upregulation upon differentiation (Figure 3f). No Irf6 protein
was detected in Irf6/ keratinocytes. Krt14 was detected at
the same level in wild-type and mutant cells, regardless of
culture conditions. However, p63 was upregulated in Irf6/
keratinocytes under similar culture conditions. After induc-
tion of differentiation, p63 level decreased in wild-type
keratinocytes, whereas it remained highly expressed in Irf6/
keratinocytes. These data suggest that Irf6 is required to
downregulate p63 as keratinocytes are induced to differenti-
ate. Krt10, Krt1, and involucrin, markers of early epidermal
differentiation, were expressed in both wild-type and Irf6/
epidermis (Supplementary Figure S1 online) and cultures
under differentiation conditions, which suggests that Irf6 is
not necessary for early keratinocyte differentiation. In
contrast, markers of terminal keratinocyte differentiation,
loricrin and filaggrin, were expressed only in wild-type
keratinocytes under differentiation conditions, indicating that
Irf6 is necessary for keratinocyte terminal differentiation.
To determine whether the differentiation defect was
specific to the absence of Irf6, we infected Irf6/ keratino-
cytes with an adenovirus that expressed Irf6 (Ad-Irf6) or
green fluorescent protein (Ad-GFP) under the control of the
cytomegalovirus promoter (Bailey et al., 2008a). All kerati-
nocytes were successfully infected with the viral
construct with no apparent toxicity (Figure 3c). Cellular size
was similar between the groups, yet slightly increased
compared with non-transfected keratinocytes (Ad-
IRF6¼ 1,352±66 mm2, N¼ 4; Ad-GFP¼1,429±66 mm2,
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Figure 2. Irf6 restricts the long-term proliferative potential of keratinocytes. Percentage of BrdU incorporation is the ratio of BrdU-positive cells over the
total number of keratinocytes (top left). The distribution of keratinocytes in the cell cycle was determined from DNA content and is expressed as percentage of
total cells (top right). The numbers of cells 6 and 10 days after plating were plotted as a function of time (bottom left). Colony-forming efficiency (CFE) assay was
performed and the number of colonies (shown by the representative macroscopic view, bottom middle) was counted and the percentage of CFE calculated for
Irf6þ /þ and Irf6/ keratinocytes. Data are averages of three to five independent experiments (total N of 4–8 per group)±SEM. *Po0.05; **Po0.01 after
Student’s t-test. Irf6, Interferon Regulatory Factor 6.
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N¼6; averages±SEM). Under differentiation conditions,
only a few Ad-Irf6-transfected Irf6/ keratinocytes appeared
stratified, suggesting only partial differentiation compared
with wild-type cells (Figure 3b). Ad-Irf6-transfected Irf6/
keratinocytes expressed Irf6 protein at a higher level than
endogenous level as shown by western blot (Figure 3f). The
level of Krt14 was unchanged after transfection, whereas the
level of p63 was reduced compared with Irf6/ keratinocytes
under differentiation conditions. In addition, Ad-Irf6-transfected
Irf6/ keratinocytes expressed Krt1 and involucrin at a higher
level than in mutant cells, whereas Krt10 was expressed at a
higher level than in wild-type cells. However, despite
abundant Irf6, these keratinocytes did not express filaggrin or
loricrin (Figure 3f). Expression of all these proteins in Irf6/
keratinocytes transfected with Ad-GFP were identical to Irf6/
keratinocytes, indicating no impact of the transfection itself on
these markers. These observations suggest that Irf6 regulates
p63, but reintroduction of Irf6 was not sufficient to achieve
terminal differentiation of keratinocytes.
Irf6 is not sufficient to promote keratinocyte differentiation
To explore the extent to which Irf6 is sufficient to induce
keratinocyte differentiation, we used the Ad-Irf6 to over-
express Irf6 in wild-type embryonic keratinocytes (Figure 4).
Keratinocytes transfected with a GFP-expressing vector (Ad-
GFP) exhibited identical morphological features compared
with Ad-Irf6 keratinocytes. Both groups showed cobblestone-
like cells under growing conditions in NMedium (Figure 4c
and d), and the presence of stratified cells consistent with
differentiation in medium with calcium (Figure 4a, b, e and f).
Under growing conditions, we did not observe stratification
in cells overexpressing Irf6. Western blot analysis confirmed
the overexpression of Irf6 in cells transfected with Ad-Irf6
compared with Ad-GFP control (Figure 4g). Both wild-type
and overexpressing Irf6 keratinocytes exhibited a similar
protein expression profile, indicating that Irf6 alone is not
sufficient to induce keratinocyte differentiation. However,
levels of p63, Krt10, Krt1, loricrin, and filaggrin varied with
culture conditions, with markers of differentiation being
detected only in K0.15, and p63 only under low calcium
concentration. NMedium supplemented with calcium was
not sufficient to induce expression of differentiation markers,
leading to the hypothesis that other components of these
media influence keratinocyte differentiation in vitro.
The MCS9.7 enhancer region regulates Irf6 in adult
keratinocytes
Recently, an enhancer of Irf6 was identified (Rahimov et al.,
2008). This enhancer, termed MCS9.7, was sufficient to
express a reporter gene in tissues that express endogenous
Irf6, including the epithelial layers of developing limb buds
and craniofacial structures at e11 (Rahimov et al., 2008) and
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Figure 3. Irf6 is necessary for terminal differentiation of keratinocytes in vitro. Phase-contrast images of Irf6þ /þ (a, b) and Irf6/ keratinocytes (c–e) 24 hours
in LoCal (a, d) or 72 hours in keratinocyte serum-free medium supplemented with 0.15mM CaCl2 (K0.15) to induce differentiation (b, c, e). Irf6
/ keratinocytes
were transfected with an adenoviral construct containing Irf6 (AdI) or green fluorescent protein (AdG) complementary DNA. (f) Western blot analysis of
protein extracts from cultured keratinocytes or embryonic skin for Irf6, Krt14, p63, Krt10, Krt1, involucrin (Inv), loricrin (Lor), and filaggrin (FG; profilaggrin is
also detected by this antibody and indicated as ProFG). Molecular weight for each protein is indicated. Black arrow in f indicates processed filaggrin in Irf6þ /þ
skin; * indicates nonspecific band. Bar¼ 100mm. Irf6, Interferon Regulatory Factor 6; Krt, Keratin.
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in the epidermis at e17.5 (Sperber, 2010). As Irf6 is critical for
epidermal morphogenesis, we asked whether this enhancer
regulates Irf6 in adult skin and keratinocytes in culture. We
performed 5-bromo-4-chloro-3indolyl [b]-D-galactopyrano-
side (X-gal) staining on adult murine epidermis and detected
strong b-galactosidase activity throughout the suprabasal
layers of the epidermis (Figure 5a). This expression pattern
recapitulates that of Irf6 protein (Figure 5a).
We took advantage of our in vitro differentiation assay to
test whether upregulation of Irf6 after differentiation was
under the activity of the MCS9.7 enhancer. We extracted tail
keratinocytes from adult mice positive and negative for the
MCS9.7–LacZ transgene. Under growing conditions, we
detected little or no b-galactosidase activity (Figure 5b), even
though Irf6 was expressed in these cells (Figure 5c). However,
under differentiating conditions, we observed strong
b-galactosidase activity in stratified keratinocytes, which
correlated with stronger expression of Irf6 in these cells
(Figure 5c). These data confirm that MCS9.7 functions as an
enhancer, but demonstrate that, in vitro, MCS9.7 is restricted
to the most differentiated cells, whereas Irf6 has a broader
profile of expression. Therefore, these data are further
evidence that MCS9.7 contributes to the regulation of Irf6
in keratinocytes.
DISCUSSION
In this study, we showed that Irf6 was a critical regulator of
proliferation and differentiation in keratinocytes in culture.
In addition, we complemented, in murine keratinocytes,
previous studies that demonstrated the regulation of steady-
state levels of p63 by Irf6 (Moretti et al., 2010; Thomason
et al., 2010). Finally, we better defined the enhancer activity
of MCS9.7, an MCS near IRF6.
By culturing Irf6/ keratinocytes for the first time, we
tested the hypothesis that Irf6 functions in a keratinocyte-
autonomous manner in regulating proliferation and differ-
entiation. Phase-contrast observations revealed the presence
of large keratinocytes among smaller cobblestone-like
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Figure 4. Overexpression of Irf6 does not induce keratinocyte differentiation. (a–f) Microscopic phase-contrast images of Irf6þ /þ keratinocytes were
transfected with an adenoviral construct (Ad) containing either (a, c, e) Irf6 (I) or (b, d, f) green fluorescent protein (G) complementary DNA. Cultures were then
purged of growth factors and grown in keratinocyte serum-free medium with 0.15mM CaCl2 (K0.15), NMedium (N0.06), or NMedium with 0.15mM CaCl2
(N0.15) for 72 hours. (g) Proteins were extracted for western blot analysis and probed for Irf6, Krt14, p63, Krt10, Krt1, loricrin (Lor), and filaggrin (profilaggrin
is also detected by this antibody and indicated as ProFG; * indicates nonspecific band). Molecular weight for each protein is indicated. Bar¼ 100mm.
Irf6, Interferon Regulatory Factor 6; Krt, Keratin.
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keratinocytes in the absence of Irf6. This phenotypic
difference appeared intrinsic to the cells as this phenotype
was maintained after subculture. An increase in cellular size
can be indicative of epithelial-to-mesenchymal transition
(Lamouille and Derynck, 2007) or cellular stress such as
wound repair (Martin, 1997). We detected the presence of
Krt14 while vimentin was absent from Irf6/ keratinocytes,
indicating that Irf6/ keratinocytes did not undergo epithe-
lial-to-mesenchymal transition. Furthermore, cellular volume
was unchanged, suggesting that the larger cellular size may
be due to cellular spreading (Lamouille and Derynck, 2007).
Thus, Irf6 is necessary to maintain keratinocyte size, but not
epithelial phenotype.
Recent work demonstrated a regulatory relationship
between Irf6 and p63. Our western blot experiments showed
an inverse relationship between the steady-state levels of
Irf6 and p63, confirming that Irf6 represses p63 expression.
In their studies, Moretti et al. (2010) overexpressed Irf6 in
human keratinocytes and found a reduction in colony-
forming efficiency (CFE), indicating that Irf6 regulates the
proliferative potential of keratinocytes. In our complementary
studies, we observed that Irf6/ murine keratinocytes were
more efficient at forming colonies. These results were
consistent with an increase in the number of mutant
keratinocytes compared with wild-type cells in the long-term
proliferation. Short-term, however, proliferation and cell
cycle profile were similar between wild-type and mutant
cells. Together, our results indicate that the initial prolifera-
tion of keratinocytes in culture is not Irf6 dependent.
However, it appears that the absence of Irf6 leads to
persistence of, or selection for, a population of keratinocytes
with a high proliferation potential, which after a lag time of a
few days initiate division. This translates into an increase
in cellular proliferation and CFE. This cellular behavior
observed in Irf6-deficient keratinocytes is reminiscent
of keratinocytes with stem cell properties (Dunnwald
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MCS9.7–LacZ –
MCS9.7–LacZ + MCS9.7–LacZ +
MCS9.7–LacZ +
K0.15K0.15 N0.06N0.06
Figure 5. The MCS9.7 enhancer regulates Irf6 in adult epidermis and keratinocytes. (a) X-gal staining of MCS9.7–LacZ-negative (MCS9.7–LacZ, left) and
MCS9.7–LacZ-positive (MCS9.7–LacZþ ) adult tail skin (middle), both counterstained with hematoxylin. Immunofluorescent staining of Irf6 (red) on
MCS9.7–LacZ-positive adult tail skin (right). Nuclear DNA is labeled with 4,6-diamidino-2-phenylindole (blue). (b) X-gal staining of MCS9.7–LacZ-negative
and MCS9.7–LacZ-positive keratinocytes under growing (N0.06) and differentiation conditions (K0.15). (c) Immunofluorescent staining of Irf6 (red) and p63
(green) on MCS9.7–LacZ-negative and MCS9.7–LacZ-positive keratinocytes under growing and differentiation conditions. Bar¼ 100mm. Irf6, Interferon
Regulatory Factor 6; MCS, multispecies conserved sequence; X-gal, 5-bromo-4-chloro-3indolyl [b]-D-galactopyranoside.
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et al., 2003a). As epidermal stem cells have been described
as more ‘‘sticky’’ than more differentiated cells (Jones and
Watt, 1993; Bickenbach and Chism, 1998; Kaur and Li,
2000), it is tempting to propose that Irf6 has a role in cellular
adhesion. In this vein, it is interesting to note that Irf6-
deficient mice exhibit oral adhesion, fusion of the gastro-
intestinal tract, and syndactyly, all of which are forms of
adhesion defects. It is noteworthy that we did not detect the
presence of apoptotic cells under basal growth conditions
regardless of the level of Irf6 in keratinocytes (data not
shown). Furthermore, previous data in mammary epithelial
cells showed that Irf6 promotes quiescence by favoring entry
into the G(0) phase of the cell cycle (Bailey and Hendrix,
2008b). In addition, adenoviral reexpression of Irf6 in breast
cancer cells that had lost Irf6 expression significantly reduced
cellular proliferation (Bailey et al., 2008a). Together, these
data strongly support a role for Irf6 as a repressor of long-term
keratinocyte proliferation.
A vital role for Irf6 in epidermal differentiation was first
observed in vivo (Ingraham et al., 2006), and thus we asked
whether Irf6/ keratinocytes were competent to undergo
differentiation in vitro. We observed that Irf6 was not
necessary for early keratinocyte differentiation as we detected
Krt10, Krt1, and involucrin in Irf6/ keratinocytes after
in vitro induction of differentiation. Conversely, Irf6 was
required to achieve terminal keratinocyte differentiation, as
loricrin and filaggrin were absent from calcium-induced
differentiated Irf6/ keratinocytes. These results confirm our
previous in vivo data, indicating the presence of early
differentiation markers and the absence of later differentiation
markers in Irf6/ epidermis, and suggest that Irf6 might
differentially regulate different aspects of keratinocyte differ-
entiation. The reintroduction of Irf6 by adenovirus rescued
stratification in mutant keratinocytes, although to a lesser
extent than in wild type. These phenotypic changes were
accompanied by the expected increase in Krt10, Krt1, and
involucrin and decrease in p63 expression, but lacked the
expected expression of loricrin and profilaggrin. These data
suggest that only partial rescue was achieved, despite
Irf6 levels being above that of endogenous levels. Other
regulatory elements or cofactors may be required to fully
rescue the Irf6/ phenotype. Although Irf6 is expressed
at low levels in basal conditions, it is upregulated upon
differentiation. It is possible that the cellular environment
of factors under growth conditions does not support Irf6-
induced differentiation.
Although Irf6 is necessary for keratinocyte differentiation,
we observed that it is not sufficient. Overexpression of Irf6
did not induce stratification in growth medium nor did it
detectably alter stratification in differentiation medium. These
results indicate that Irf6 alone cannot induce keratinocyte
differentiation. Interestingly, keratinocyte serum-free medium
with 0.15mM CaCl2 was the only medium permissive to
keratinocyte differentiation. Addition of the same concentra-
tion of calcium to NMedium promoted stratification, but
Krt10 or Krt1 were not detected. However, addition of
calcium decreased p63 levels, suggesting a potential
calcium-dependent regulation of p63.
Finally, we observed that MCS9.7, the recently identified
enhancer of IRF6 (Rahimov et al., 2008), was active in some
but not all culture conditions. Specifically, we observed no
b-galactosidase activity in growing keratinocytes and a strong
upregulation of activity in differentiated keratinocytes.
However, we showed that Irf6 is present under both
conditions. Possible explanations for these observations are
the artificial nature of cell culture, potential lag time between
the signal for transcription and the translation of Irf6, and
differences between antibody staining for protein and
colorimetric stain for a reporter enzyme activity. Further-
more, other regulatory elements may be required for Irf6
expression under basal conditions. We also demonstrated
that the MCS9.7 is present, with strong expression in the
suprabasal layers of the adult murine epidermis, which
recapitulates the localization of the Irf6 protein.
In summary, we have shown that Irf6 regulates long-term
proliferation and is necessary, but not sufficient, to induce
keratinocyte terminal differentiation. Cell cycle regulation
and keratinocyte differentiation are critical to cutaneous
wound healing and cancer, in which Irf6 could have a critical
role (Bailey et al., 2008a; Jones et al., 2010).
MATERIALS AND METHODS
Mice
All mice were cared for according to the ACURF at the University of
Iowa. Two distinct Irf6 mutant strains were used interchangeably to
obtain Irf6-deficient embryos, Irf6gt1/þ and Irf6del1/þ . The Irf6gt1
allele was previously described (Ingraham et al., 2006). The Irf6del1
allele is a deletion of exons 3 and 4, which removed critical
sequences in the DNA-binding domain, created a frameshift, and
was the product of recombination of a conditional knockout allele
for Irf6 carrying loxP sites in introns 2 and 4 (A Kinoshita and BC
Schutte, unpublished data). The MCS9.7–LacZ is a stable transgenic
mouse strain that carries the same MCS9.7–LacZ transgene used
previously for transient transgenic analysis (Rahimov et al., 2008).
This transgene fuses MCS9.7, a multispecies conserved sequence
with enhancer activity, to the reporter gene LacZ. Briefly, the 607 bp
sequence element of MCS9.7 was cloned into the XbaI site of the
Hsp68 expression plasmid, upstream from the SV40 basal promoter,
the lacZ reporter gene, and the SV40 polyA site. Transgenic mice
were generated with this vector by standard procedures at the
University of Iowa transgenic facility, using the C57BL/6 strain.
Genotyping for the Irf6gt1 allele was performed as described
(Ingraham et al., 2006). Conditions for genotyping of the Irf6del1
allele were as follows: f: 50-gcagagtggagcacacttca-30, r: 50-ttcactga
gaaagcagcaatg-30; 2minutes 95 1C, 35 cycles of 15 seconds at 95 1C,
15 seconds at 63 1C, 45 seconds at 72 1C, and a final 5minutes at
72 1C. Conditions for genotyping of the MCS9.7–LacZ transgene
were previously described (Rahimov et al., 2008), 5minutes at
94 1C, 35 cycles of 30 seconds at 95 1C, 45 seconds at 58 1C,
60 seconds at 68 1C, and a final 3minutes at 68 1C. Homozygous and
heterozygous animals were used interchangeably as the PCR
conditions do not distinguish between the two genotypes.
Keratinocyte culture, CFE, and transfection
The presence of a copulatory plug is designated as embryonic (e)
0.5. Skin from e17.5 embryos or adult tail was incubated with
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5Uml1 Dispase II (Roche Diagnostics, Indianapolis, IN) at 4 1C for
4 hours and 2.5Uml1 Dispase II overnight, respectively. The
epidermis was peeled from the dermis and incubated in 0.25%
trypsin (Gibco Invitrogen, Carlsbad, CA) for 20minutes at 37 1C.
Keratinocytes were grown in NMedium (Hager et al., 1999) and
used after their first passage. To induce differentiation, cells were
grown in keratinocyte serum-free medium (Gibco Invitrogen) with
0.15mM CaCl2, or NMedium with 0.15mM CaCl2. To assay cellular
proliferation, cells were trypsinized 6 and 10 days after plating. Cells
were counted using a Coulter Counter (Beckman Coulter, Brea, CA).
Transfection was performed with polybrene at 10 multiplicity of
infection with adenoviral vectors containing either Irf6 or GFP
(Bailey et al., 2008a).
CFE assay was performed as originally described (Rheinwald and
Green, 1975). Briefly, 5 103 keratinocytes were plated on collagen
IV-coated 60mm dishes and grown for 12 days. Cells were stained
with 25% Giemsa stain and fixed in Giordano buffer (37%
formaldehyde, 0.66% (w/v) KH2PO4, 0.32% (w/v) Na2HPO4).
Colonies were counted and percentage of CFE was calculated.
Cellular area was measured using ImageJ (http://rsbweb.nih.gov/
ij/). Seven images of wild-type and six images of Irf6/ keratinocytes
were used, and a minimum of 100 cells per image was measured.
Cellular volume was obtained after trypsinized keratinocytes
were analyzed with a Coulter Counter (Beckman Coulter). Samples
were run in triplicate and averages of 6–7 samples per group were
calculated.
Antibodies
Rabbit polyclonal antibody against Irf6 was described previously
(Bailey et al., 2005). Rabbit anti-mouse vimentin (Muller et al., 2009)
was a generous gift from Dr Kroeger and Dr Magin (University of
Bonn, Germany). Rabbit polyclonal antibodies against Krt14, Krt10,
Krt1, involucrin, and loricrin were obtained from Covance (Emery-
ville, CA). Rabbit polyclonal antibody against filaggrin and mAb
against b-actin were obtained from Sigma (St Louis, MO). Rat
polyclonal antibody against BrdU was obtained from Abcam
(Cambridge, MA). mAb against p63 and anti-rabbit horseradish
peroxidase secondary were obtained from Santa Cruz (Santa Cruz,
CA). Anti-mouse horseradish peroxidase secondary was from GE
Healthcare (Piscataway, NJ).
Cell cycle analysis and BrdU incorporation
Four days after plating, keratinocytes were trypsinized and incubated
in hypotonic propidium iodide as described (Dunnwald et al.,
2003a). For BrdU incorporation, keratinocytes were plated on
coverslips and incubated for 2 hours in 10 mM BrdU (Sigma). After
fixation in methanol–acetone (70–30%, v/v), the DNA was denatured
with HCl, according to the manufacturer’s instructions (Abcam), and
cells were washed in phosphate-buffered saline. Cells were
incubated with an anti-BrdU antibody and counterstained with
4,6-diamidino-2-phenylindole. Total number of cells and BrdU-
positive cells were counted and the percentage of BrdU-positive
calculated. Over 1,000 cells were analyzed per group.
Protein analysis
Radioimmunoprecipitation assay and urea-tris (Dunnwald et al.,
2003b) extraction buffers were used for protein preparation. Equal
amounts of protein were separated on 10% Bis-Tris (Invitrogen)
SDS-PAGE gels under denaturing conditions. Proteins were trans-
ferred onto polyvinylidene fluoride membranes (BioRad Labora-
tories, Hercules, CA), blocked in 10% nonfat dry milk and incubated
in primary antibodies. After incubation with horseradish peroxidase-
conjugated secondary IgG antibodies, antigen detection was
performed with the chemiluminescent detection system ECL (GE
Healthcare).
Immunofluorescence
Keratinocytes in passage 1 were grown on collagen IV-coated
coverslips under different culture conditions and fixed as described
(Michel et al., 1996). After blocking with 3% goat serum (Vector
Laboratories, Burlingame, CA), cells were incubated with primary
antibodies, washed in phosphate-buffered saline, and incubated in
secondary antibodies. 4,6-diamidino-2-phenylindole was used as a
nuclear stain. Images were viewed with a Nikon Eclipse E800
(Melville, NY) and acquired with a SPOT RT Slider CCD camera
using Spot Advanced software (Diagnostic Instruments, Sterling
Heights, MI). Black and white images were pseudocolorized and
merged. For confocal microscopy, images were acquired using a
Zeiss LSM 710 microscope (Thornwood, NY) and ZEN 2009
software (Thornwood, NY).
X-gal staining
X-gal staining was performed by fixing the cells in 2% formaldehyde,
0.5 M sodium phosphate buffer, 0.2% glutaraldehyde, 0.01% sodium
deoxycholate, and 0.2% NP-40. Cultured keratinocytes and skin
sections were stained with X-gal solution (0.3 M sodium phosphate
buffer, 4mM MgCl2, 10mM K3Fe(CN)6, 10mM K4Fe(CN)6, 0.03%
sodium deoxycholate, 0.06% NP-40, and 8.4mM X-gal). Tissue
sections were counterstained with hematoxylin.
Statistics
Data are averages of at least three biological replicates. Statistical
analysis was performed with appropriate tests for each study as
indicated in the figure legend.
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